{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:34:11Z","timestamp":1791052451363,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although chronic graft-versus-host disease (cGVHD) is a major long-term complication of allogeneic hematopoietic stem cell transplantation, little is known of its pathogenesis. We have systematically examined oral mucosa among cGVHD patients and determined that the clinical severity of oral cGVHD was correlated with apoptotic epithelial cells, often found adjacent to infiltrating effector-memory T cells expressing markers of cytotoxicity and type I cytokine polarization. Accumulation of T-bet+ T-cell effectors was associated with both increased proliferation and the expression of the type I chemokine receptor CXCR3. Concurrently, in both infiltrating cells and keratinocytes, we observed increased expression of the CXCR3 ligand MIG (CXCL9) and interleukin-15 (IL-15), type I interferon (IFN)\u2013inducible factors that support the migration, type I differentiation, and expansion of alloreactive effectors. In severely affected mucosa, we observed high levels of MxA, a protein specifically induced by type I IFN, and signal transducer and activator of transcription 1 (STAT1) phosphorylation, a critical step in the IFN-signaling pathway, along with increased numbers of plasmacytoid dendritic cells. These data challenge the current paradigm of cGVHD as a type II cytokine\u2013driven disorder and support the model that oral cGVHD results from type I IFN\u2013driven immigration, proliferation, and differentiation of T-bet+ type I T effectors. The clinical trials are registered at http:\/\/www.clinicaltrials.gov as NCT00331968.<\/jats:p>","DOI":"10.1182\/blood-2008-07-168351","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T02:50:30Z","timestamp":1232765430000},"page":"3620-3630","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["Increased T-bet+ cytotoxic effectors and type I interferon\u2013mediated processes in chronic graft-versus-host disease of the oral mucosa"],"prefix":"10.1182","volume":"113","author":[{"given":"Matin M.","family":"Imanguli","sequence":"first","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Swaim","sequence":"additional","affiliation":[{"name":"Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH), Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy C.","family":"League","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Gress","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances T.","family":"Hakim","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713565167600_B1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000245689.47333.ff","article-title":"Chronic graft versus host disease.","volume":"13","author":"Baird","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"2019111713565167600_B2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","article-title":"Murine models of chronic graft-versus-host disease: insights and unresolved issues.","volume":"14","author":"Chu","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111713565167600_B3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.150.2.361","article-title":"Preferential activation of Th2 cells in chronic graft-versus-host reaction.","volume":"150","author":"De Wit","year":"1993","journal-title":"J Immunol"},{"key":"2019111713565167600_B4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1189\/jlb.0407227","article-title":"Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.","volume":"82","author":"Giorgini","year":"2007","journal-title":"J Leukoc Biol"},{"key":"2019111713565167600_B5","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2007-05-091074","article-title":"Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.","volume":"110","author":"Chen","year":"2007","journal-title":"Blood"},{"key":"2019111713565167600_B6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1600-0714.2005.00322.x","article-title":"Chronic GVHD in minor salivary glands and oral mucosa: histopathological and immunohistochemical evaluation of 25 patients.","volume":"34","author":"Soares","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"2019111713565167600_B7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0714.2005.00372.x","article-title":"Immunohistopathological study of the oral lichenoid lesions of chronic GVHD.","volume":"35","author":"Sato","year":"2006","journal-title":"J Oral Pathol Med"},{"key":"2019111713565167600_B8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"key":"2019111713565167600_B9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I, diagnosis and staging working group report.","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111713565167600_B10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/10454411970080020701","article-title":"Graft-vs.-host disease.","volume":"8","author":"Woo","year":"1997","journal-title":"Crit Rev Oral Biol Med"},{"key":"2019111713565167600_B11","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"2019111713565167600_B12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0014-5793(99)01598-7","article-title":"The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures.","volume":"463","author":"Flohr","year":"1999","journal-title":"FEBS Lett"},{"key":"2019111713565167600_B13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II, Pathology Working Group Report.","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111713565167600_B14","first-page":"13","article-title":"Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis.","volume":"414","author":"Mazumder","year":"2008","journal-title":"Methods Mol Biol"},{"key":"2019111713565167600_B15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment.","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"2019111713565167600_B16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1490","article-title":"Recent developments in the transcriptional regulation of cytolytic effector cells.","volume":"4","author":"Glimcher","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2019111713565167600_B17","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease.","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"key":"2019111713565167600_B18","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2005-04-1393","article-title":"T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.","volume":"106","author":"Lord","year":"2005","journal-title":"Blood"},{"key":"2019111713565167600_B19","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.177.9.5890","article-title":"T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity.","volume":"177","author":"Taqueti","year":"2006","journal-title":"J Immunol"},{"key":"2019111713565167600_B20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4+ effector memory T cell production and tissue emigration in nonhuman primates.","volume":"116","author":"Picker","year":"2006","journal-title":"J Clin Invest"},{"key":"2019111713565167600_B21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.immuni.2006.03.016","article-title":"Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.","volume":"24","author":"Yu","year":"2006","journal-title":"Immunity"},{"key":"2019111713565167600_B22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ni1268","article-title":"Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.","volume":"6","author":"Intlekofer","year":"2005","journal-title":"Nat Immunol"},{"key":"2019111713565167600_B23","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2006-04-019059","article-title":"Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity.","volume":"108","author":"Blaser","year":"2006","journal-title":"Blood"},{"key":"2019111713565167600_B24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/ar1202","article-title":"Targeting the interleukin-15\/interleukin-15 receptor system in inflammatory autoimmune diseases.","volume":"6","author":"Waldmann","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"2019111713565167600_B25","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo.","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"2019111713565167600_B26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"},{"key":"2019111713565167600_B27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases.","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"2019111713565167600_B28","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1128\/JVI.00546-06","article-title":"Induction of MxA gene expression by influenza A virus requires Type I or Type III interferon signaling.","volume":"81","author":"Holzinger","year":"2007","journal-title":"J Virol"},{"key":"2019111713565167600_B29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling.","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2019111713565167600_B30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coi.2006.11.004","article-title":"Innate immune functions of plasmacytoid dendritic cells.","volume":"19","author":"Cao","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"2019111713565167600_B31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.20041961","article-title":"Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.","volume":"202","author":"Yoneyama","year":"2005","journal-title":"J Exp Med"},{"key":"2019111713565167600_B32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/79747","article-title":"Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.","volume":"1","author":"Cella","year":"2000","journal-title":"Nat Immunol"},{"key":"2019111713565167600_B33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon-\u03b1\/\u03b2-producing cells) accumulate in cutaneous lupus erythematosus lesions.","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"2019111713565167600_B34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production.","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"2019111713565167600_B35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"2019111713565167600_B36","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":"Novel markers of normal and neoplastic human plasmacytoid dendritic cells.","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"2019111713565167600_B37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1084\/jem.20060626","article-title":"Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue.","volume":"204","author":"Alcaide","year":"2007","journal-title":"J Exp Med"},{"key":"2019111713565167600_B38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.20031819","article-title":"Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.","volume":"200","author":"Bettelli","year":"2004","journal-title":"J Exp Med"},{"key":"2019111713565167600_B39","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1073\/pnas.2636938100","article-title":"Antigen-driven effector CD8 T cell function regulated by T-bet.","volume":"100","author":"Sullivan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713565167600_B40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.jid.5700945","article-title":"Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis.","volume":"128","author":"Wenzel","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2019111713565167600_B41","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.174.9.5507","article-title":"Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo.","volume":"174","author":"R\u00fcckert","year":"2005","journal-title":"J Immunol"},{"key":"2019111713565167600_B42","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1073\/pnas.092675799","article-title":"IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells.","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713565167600_B43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2002.tb05940.x","article-title":"IL-15 is a growth factor and an activator of CD8 memory T cells.","volume":"975","author":"Weng","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"2019111713565167600_B44","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/jid.2008.96","article-title":"An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor Antigens is a common pathogenetic feature in \u201cinterface dermatitis.\u201d","volume":"128","author":"Wenzel","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2019111713565167600_B45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus.","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"},{"key":"2019111713565167600_B46","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2019111713565167600_B47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbmt.2007.12.494","article-title":"Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.","volume":"14","author":"Rajasekar","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111713565167600_B48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2019111713565167600_B49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1176","article-title":"Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.","volume":"11","author":"Lang","year":"2005","journal-title":"Nat Med"},{"key":"2019111713565167600_B50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"2019111713565167600_B51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.2007.00574.x","article-title":"High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.","volume":"220","author":"Bianchi","year":"2007","journal-title":"Immunol Rev"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/15\/3620\/1484367\/zh801509003620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/15\/3620\/1484367\/zh801509003620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T19:00:15Z","timestamp":1684868415000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/15\/3620\/24979\/Increased-Tbet-cytotoxic-effectors-and-type-I"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,9]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-168351","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,9]]}}}